checkAd
    ImmunoPrecise Antibodies Aktie
    1,1400
     
    EUR
    -0,87 %
    -0,0100 EUR
    Letzter Kurs 08:21:17 Lang & Schwarz
    1,0600
     
    EUR
    3.788 STK
    Geldkurs 08:21:17
    1,2200
     
    EUR
    3.788 STK
    Briefkurs 08:21:17
    ISIN: CA45257F2008 · WKN: A2QJEC · Kanada

    Neueste Nachrichten

    Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results
    22.04.24 · Accesswire · ImmunoPrecise Antibodies
    ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments
    12.04.24 · Accesswire · ImmunoPrecise Antibodies
    InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
    28.03.24 · Business Wire (engl.) · ImmunoPrecise Antibodies
    IPA Acquires the Carterra LSA Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
    20.03.24 · Business Wire (engl.) · ImmunoPrecise Antibodies
    IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
    14.03.24 · Business Wire (engl.) · ImmunoPrecise Antibodies
    ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology
    08.03.24 · Accesswire · ImmunoPrecise Antibodies
    IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
    07.03.24 · Business Wire (engl.) · ImmunoPrecise Antibodies
    IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
    04.03.24 · Business Wire (engl.) · ImmunoPrecise Antibodies
    IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
    14.12.23 · Business Wire (engl.) · ImmunoPrecise Antibodies
    IPA Announces Closing of $1.265 Million Public Offering of Common Shares
    08.12.23 · Business Wire (engl.) · ImmunoPrecise Antibodies
    ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
    07.12.23 · Accesswire · ImmunoPrecise Antibodies
    IPA Announces Pricing of $1.1 Million Public Offering of Common Shares
    06.12.23 · Business Wire (engl.) · ImmunoPrecise Antibodies